Inc. ( an integrated pharmaceutical company dedicated to the worldwide development and commercialization of impactful ...

Janus Henderson, Coastal Financial, Novartis, Apogee and InterDigital have been highlighted in this Screen of The Week ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

The accuracy of skin cancer diagnosis varied by lesion type, physician specialty and experience, and examination method, with ...

Midtown-based drug discovery company Schrodinger has entered a deal to advance multiple projects with pharmaceutical giant ...

Partnered with multiple neuroscience pharmaceutical companies, including Bright Minds Bioscience, and neurologists to advance ...

Johnson & Johnson seeks to charge 340B-enrolled disproportionate share hospitals full price for Xarelto and Stelara and issue ...

United Therapeutics' pipeline and Tyvaso DPI drive strong growth. Read why UTHR stock offers substantial upside with ...

UBS analyst Matthew Weston maintained a Buy rating on Novartis AG (NOVN – Research Report) today and set a price target of CHF111.00. According to TipRanks, Weston is ranked #1736 out of 9162 analysts ...

Researchers from organizations with new access to Truveta Data include American Heart Association, Bayer, Edwards Lifesciences, Eli Lilly and Co., Gates Ventures, GORE, Impulse Dynamics, Indiana ...